Lupin receives tentative approval from USFDA for Dapagliflozin and Saxagliptin tablets
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
The company has received five final approvals
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
10+ emerging markets, Japan & ANZ transition in final phase
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
Subscribe To Our Newsletter & Stay Updated